Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.

IF 3.3 4区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Journal of Neuroendocrinology Pub Date : 2025-01-01 Epub Date: 2024-11-26 DOI:10.1111/jne.13468
Carolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, James R Howe, Valentina Ambrosini, Susana H Belli, Mikkel Andreassen, Nehara Begum, Timm Denecke, Antongiulio Faggiano, Massimo Falconi, Jo Grey, Ulrich P Knigge, Teodora Kolarova, Bruno Niederle, Els Nieveen van Dijkum, Stefano Partelli, Andreas Pascher, Guido Rindi, Philippe Ruszniewski, Stefan Stättner, Timon Vandamme, Juan W Valle, Marie-Pierre Vullierme, Staffan Welin, Aurel Perren, Detlef K Bartsch, Gregory K Kaltsas, Gerlof D Valk
{"title":"Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.","authors":"Carolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, James R Howe, Valentina Ambrosini, Susana H Belli, Mikkel Andreassen, Nehara Begum, Timm Denecke, Antongiulio Faggiano, Massimo Falconi, Jo Grey, Ulrich P Knigge, Teodora Kolarova, Bruno Niederle, Els Nieveen van Dijkum, Stefano Partelli, Andreas Pascher, Guido Rindi, Philippe Ruszniewski, Stefan Stättner, Timon Vandamme, Juan W Valle, Marie-Pierre Vullierme, Staffan Welin, Aurel Perren, Detlef K Bartsch, Gregory K Kaltsas, Gerlof D Valk","doi":"10.1111/jne.13468","DOIUrl":null,"url":null,"abstract":"<p><p>Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation in practices. Evidence on the natural course of MEN1-related neuroendocrine tumours (NET) and the value of screening programs has increased and new imaging techniques have emerged. The aim of this study is to provide insight in the current practices of screening and surveillance for MEN1-related NETs in ENETS Centers of Excellence (CoEs). A clinical practice questionnaire was distributed among all 65 ENETS CoEs. Response rate was 91% (59/65). In 14% of CoEs <10 patients, in 50% 10-49, in 31% 50-100 and in 3 centres (5%) >100 patients with MEN1 are seen. Practices with regard to screening and surveillance of NETs were markedly heterogeneous. Differences between countries were noted in the use of gut hormones for biochemical screening and the choice for imaging modality for screening/surveillance of pancreatic NETs (PanNETs). Magnetic resonance imaging (MRI) is the preferred modality for screening and surveillance of PanNETs, whereas this is computed tomography (CT) for thoracic NETs. Practices regarding screening for thoracic NETs were more homogeneous among larger volume CoEs, with longer screening intervals. The majority of CoEs tailored the surveillance of small pancreatic and lung NETs to observed growth rate. 68% of CoEs advise patients with clinical MEN1 with negative genetic testing to undergo periodic screening like mutation-positive patients. In conclusion, there is still marked heterogeneity in practice, although there are also common trends. Differences were sometimes associated with volume or country, but often no association was found. This underscores the need for clear and evidence-based practice recommendations.</p>","PeriodicalId":16535,"journal":{"name":"Journal of Neuroendocrinology","volume":" ","pages":"e13468"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750319/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuroendocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jne.13468","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation in practices. Evidence on the natural course of MEN1-related neuroendocrine tumours (NET) and the value of screening programs has increased and new imaging techniques have emerged. The aim of this study is to provide insight in the current practices of screening and surveillance for MEN1-related NETs in ENETS Centers of Excellence (CoEs). A clinical practice questionnaire was distributed among all 65 ENETS CoEs. Response rate was 91% (59/65). In 14% of CoEs <10 patients, in 50% 10-49, in 31% 50-100 and in 3 centres (5%) >100 patients with MEN1 are seen. Practices with regard to screening and surveillance of NETs were markedly heterogeneous. Differences between countries were noted in the use of gut hormones for biochemical screening and the choice for imaging modality for screening/surveillance of pancreatic NETs (PanNETs). Magnetic resonance imaging (MRI) is the preferred modality for screening and surveillance of PanNETs, whereas this is computed tomography (CT) for thoracic NETs. Practices regarding screening for thoracic NETs were more homogeneous among larger volume CoEs, with longer screening intervals. The majority of CoEs tailored the surveillance of small pancreatic and lung NETs to observed growth rate. 68% of CoEs advise patients with clinical MEN1 with negative genetic testing to undergo periodic screening like mutation-positive patients. In conclusion, there is still marked heterogeneity in practice, although there are also common trends. Differences were sometimes associated with volume or country, but often no association was found. This underscores the need for clear and evidence-based practice recommendations.

欧洲神经内分泌肿瘤学会卓越中心(ENETS CoE)对多发性内分泌肿瘤 1 型相关神经内分泌肿瘤的筛查和监测方法--ENETS MEN1 特别工作组问卷调查研究。
多发性内分泌肿瘤 1 型(MEN1)临床实践指南》(2012 年)主要基于专家意见,因为当时可用的证据有限,因此存在解释和实践差异的空间。有关MEN1相关神经内分泌肿瘤(NET)自然病程和筛查计划价值的证据不断增加,新的成像技术也不断涌现。本研究旨在深入了解ENETS卓越中心(CoEs)目前筛查和监测MEN1相关NET的做法。我们向所有 65 个 ENETS CoE 发放了临床实践调查问卷。回复率为 91%(59/65)。14%的CoE接诊了100名MEN1患者。NET筛查和监测方面的做法存在明显差异。各国在使用肠道激素进行生化筛查和选择成像方式筛查/监测胰腺 NET(PanNET)方面存在差异。磁共振成像(MRI)是筛查和监测PanNETs的首选方式,而胸部NETs的首选方式是计算机断层扫描(CT)。规模较大的CoE在筛查胸部NET方面的做法较为一致,筛查间隔时间较长。大多数CoE根据观察到的生长速度对小型胰腺和肺部NET进行监测。68%的CoE建议基因检测阴性的临床MEN1患者与基因突变阳性患者一样接受定期筛查。总之,尽管存在共同的趋势,但在实践中仍存在明显的异质性。差异有时与病例数或国家有关,但往往没有关联。这凸显了明确的循证实践建议的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuroendocrinology
Journal of Neuroendocrinology 医学-内分泌学与代谢
CiteScore
6.40
自引率
6.20%
发文量
137
审稿时长
4-8 weeks
期刊介绍: Journal of Neuroendocrinology provides the principal international focus for the newest ideas in classical neuroendocrinology and its expanding interface with the regulation of behavioural, cognitive, developmental, degenerative and metabolic processes. Through the rapid publication of original manuscripts and provocative review articles, it provides essential reading for basic scientists and clinicians researching in this rapidly expanding field. In determining content, the primary considerations are excellence, relevance and novelty. While Journal of Neuroendocrinology reflects the broad scientific and clinical interests of the BSN membership, the editorial team, led by Professor Julian Mercer, ensures that the journal’s ethos, authorship, content and purpose are those expected of a leading international publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信